BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06984328-completion@plaintrial.com
DTSTAMP:20261027T094108Z
DTSTART;VALUE=DATE:20290715
SUMMARY:Study of the Effectiveness and Safety of Acasunlimab Alone and With
  Pembrolizumab to Treat Advanced Melanoma of the Skin That Has Returned Af
 ter Treatment With an Approved Checkpoint Inhibitor Therapy (ABBIL1TY MELA
 NOMA-07) — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT06984328
URL:https://plaintrial.com/trial/NCT06984328
END:VEVENT
END:VCALENDAR